Sanara MedTech Inc. (NASDAQ:SMTI) reported a significant miss in earnings per share (EPS) at -$3.40, against the estimated -$0.24.Despite a 22% revenue growth year-over-year, reaching $26.3 million, SMTI fell short of the expected $29.9 million.The company's financial metrics reveal challenges, including a negative price-to-earnings (P/E) ratio of approximately -18.30 and a high enterprise value to operating cash flow ratio of approximately 59.33.Sanara MedTech Inc. (NASDAQ: SMTI) is a company focused on me ...